Cart
sales@molnova.com
Lubiprostone
CAS No. 136790-76-6
Lubiprostone ( —— )
Catalog No. M11518 CAS No. 136790-76-6
Lubiprostone is an activator of ClC-2 chloride channels, used in the management of idiopathic chronic constipation.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 49 | In Stock |
|
| 5MG | 45 | In Stock |
|
| 10MG | 73 | In Stock |
|
| 25MG | 131 | In Stock |
|
| 50MG | 211 | In Stock |
|
| 100MG | 321 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 767 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLubiprostone
-
NoteResearch use only, not for human use.
-
Brief DescriptionLubiprostone is an activator of ClC-2 chloride channels, used in the management of idiopathic chronic constipation.
-
DescriptionLubiprostone is an activator of ClC-2 chloride channels, used in the management of idiopathic chronic constipation.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorClC-2 chloride channels
-
Research AreaMetabolic Disease
-
Indication——
Chemical Information
-
CAS Number136790-76-6
-
Formula Weight390.46
-
Molecular FormulaC20H32F2O5
-
Purity>98% (HPLC)
-
SolubilityDMSO:78 mg/mL (199.76 mM); Ethanol:78 mg/mL (199.76 mM); Water：<1 mg/mL (<1 mM)
-
SMILESCCCCC([C@]1(CC[C@H]2[C@H](O1)CC(=O)[C@@H]2CCCCCCC(=O)O)O)(F)F
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Bijvelds MJ, et al. Gastroenterology, 2009, 137(3), 976-985.
molnova catalog
related products
-
GA3-AM
GA3-AM is a cell-permeable chemical dimerizer.
-
Vopratelimab
Vopratelimab (JTX-2011) is a selective humanized immunoglobulin G1-kappa monoclonal antibody and a potent ICOS agonist with high affinity for inducible T cell co-stimulating factors (ICOS), showing affinities of 0.93 nM for hICOS, 3.7 nM for rat ICOS, and 0.64 nM for mICOS.
-
Licarin A b
Licarin A ((+)-Licarin A), a neolignan, significantly and dose-dependently reduces TNF-α production (IC50=12.6 μM) in dinitrophenyl-human serum albumin (DNP-HSA)-stimulated RBL-2H3 cells. Anti-allergic effects. Licarin A reduces TNF-α and PGD2 production, and COX-2 expression.
